Novelix Pharmaceuticals Ltd — Insider Trading, 29-06-2026: Insider Trading / SAST

Novelix Pharmaceuticals has announced the closure of its trading window for Designated Persons and their relatives. This measure becomes effective shortly and will continue until 48 hours after the company declares its unaudited financial results for the quarter recently concluded. This action aims to prevent insider trading, ensuring transparency and fairness for all shareholders ahead of the financial update. During this period, the specified individuals are prohibited from trading in the company's securities. The company will announce the date for considering these results later.